Search

Implementation of a closed system transfer device in oncology units

ReTweet

The objective of this study was to evaluate the effect of CSTD implementation on central line-associated bloodstream infection (CLABSI) rates” Fox et al (2018).

Background:

In February 2016 the United States Pharmacopeia introduced general chapter 800 requiring the use of closed system transfer devices (CSTD) for preparation and administration of antineoplastic hazardous drugs. The objective of this study was to evaluate the effect of CSTD implementation on central line-associated bloodstream infection (CLABSI) rates.



Reference:

Fox, J., Rensing, K., Rumsey, A., Grimes, L., Rojek, R., Dubberke, E., Warren, D. and Mayfield, J. (2018) The Impact on Central Line-Associated Bloodstream Infection Rates Following the Introduction of a Closed System Transfer Device in Oncology Units. American Journal of Infection Control. 46(6, Supplement), p.S64-S65.

DOI: https://doi.org/10.1016/j.ajic.2018.04.127

Facebook Twitter Linkedin Rss Envelope

About IVTEAM citation library

IVTEAM has established itself as a core global resource for infusion and vascular access practitioners. Each day 6K users have access thousands of pages of easy to access relevant intravenous news and updates. IVTEAM offers its visitors a premier service that has no financial or subscriber based restrictions. The editorial stance of IVTEAM is to ensure no editorial restrictions exist; content remains unbiased and independent.

It is crucial that IVTEAM stays up-to-date and offers visitors regular, current updates. Each day news feeds are analysed, websites searched and various additional sources of information visited. This results in large amounts of data being sifted through for relevant information every day. Only a small amount of data is relevant to IV practice and makes it onto IVTEAM.

Read more
Copyright 2025 © IVTEAM. All rights Reserved.

Register for free citation alerts

Supporting your vascular access and infusion therapy learning journey